Program
Tin Fluorides
Also written as “0.454% Stannous Fluoride Dentifrice”, “Stannous fluoride toothpaste” and “Stannous Fluoride”.
Its studies are mostly in Gingivitis · Dentin Sensitivity · Dental Plaque · Diabetes Mellitus, Type 2 · Halitosis, led by 5 companies.
Drug pageTin Fluorides: every studyMany companies study it; this page follows only the 47 they lead. All 44 studies, academic ones too, with its approvals and label.Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Colgate Palmoliveits history only | 182 open or running | phase 4since Feb 6, 2015 | Sep 26, 2008 | Sep 2027phase 4 · NCT07807397 |
| Procter and Gambleits history only | 142 open or running | phase 4since Aug 28, 2025 | Feb 28, 2012 | none ahead |
| GlaxoSmithKlineits history only | 80 open or running | phase 3since May 3, 2012 | May 3, 2012 | none ahead |
| HALEONits history only | 40 open or running | no phasesince Nov 16, 2023 | Nov 16, 2023 | none ahead |
| Church & Dwight | 30 open or running | no phasesince Feb 12, 2026 | Feb 12, 2026 | none ahead |
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and studies of Church & Dwight only; the figures above count every company.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Feb 12, 2026First studies: 2 no phase studiesFirst studyNCT07419737, NCT07425509
- Jun 2, 2026No phase study in GingivitisNCT07640399 · 133 enrolled · Canada
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 3 Church & Dwight leads, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT07640399Gingivitis · Canada | – | Completed | Jun 13, 2025 | 133 |
| NCT07425509Halitosis · United States | – | Completed | Nov 4, 2024 | 49 |
| NCT07419737Dental Plaque · United States | – | Completed | Dec 4, 2024 | 91 |
How it is read
Names in the registry
- “0.454% Stannous Fluoride Dentifrice”, 8 entries
- “Stannous fluoride toothpaste”, 7 entries
- “Stannous Fluoride”, 6 entries
- “stannous fluoride toothpaste”, 5 entries
- “Stannous Fluoride Toothpaste (SnF)”, 5 entries
Conditions, from the studies’ own filings
- Gingivitis, 20 studies
- Dentin Sensitivity, 8 studies
- Dental Plaque, 7 studies
- Diabetes Mellitus, Type 2, 1 study
- Halitosis, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.